What is Amgen's finite-lived intangible assets, net?

Amgen (AMGN) reported finite-lived intangible assets, net of $22.43B in Q3 2025.

How has Amgen's finite-lived intangible assets, net changed year-over-year?

Amgen's finite-lived intangible assets, net decreased by 19.4% year-over-year, from $27.83B to $22.43B.

What is the long-term trend for Amgen's finite-lived intangible assets, net?

Over 4 years (2020 to 2024), Amgen's finite-lived intangible assets, net has grown at a 12.6% compound annual growth rate (CAGR), from $16.56B to $26.64B.

What does finite-lived intangible assets, net mean?

The current book value of intangible assets with a limited lifespan after accounting for wear and tear.

Finite-Lived Intangible Assets, Net

Non-Current Assets

Amgen Finite-Lived Intangible Assets, Net decreased by 6.2% to $22.43B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.4%, from $27.83B to $22.43B. Over 4 years (FY 2020 to FY 2024), Finite-Lived Intangible Assets, Net shows an upward trend with a 12.6% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ4 2020

Last reportedQ3 2025

How to read this metric

A declining net value relative to gross suggests aging assets, while a stable or increasing value indicates ongoing investment or acquisitions.

Detailed definition

This is the carrying value of intangible assets with a finite life after subtracting accumulated amortization from the g...

Peer comparison

Commonly reported by all public companies; essential for comparing asset quality and amortization policies against industry peers.

Metric ID: finite_lived_intangible_assets_net

Historical Data

18 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25
Value	$15.28B	$14.63B	$14.11B	$13.55B	$12.91B	$12.26B	$15.07B	$14.38B	$13.69B	$12.99B	$31.42B	$30.22B	$29.02B	$27.83B	$26.64B	$24.66B	$23.90B	$22.43B
QoQ Change	—	-4.2%	-3.5%	-4.0%	-4.7%	-5.0%	+23.0%	-4.6%	-4.8%	-5.1%	+141.9%	-3.8%	-4.0%	-4.1%	-4.3%	-7.4%	-3.1%	-6.2%
YoY Change	—	—	—	—	-15.5%	-16.2%	+6.8%	+6.2%	+6.1%	+6.0%	+108.5%	+110.1%	+112.0%	+114.2%	-15.2%	-18.4%	-17.6%	-19.4%

Range$12.26B – $31.42B

CAGR+9.5%

Avg YoY Growth+26.2%

Median YoY Growth+6.0%

Current Streak7 quarters decline

Frequently Asked Questions

What is Amgen's finite-lived intangible assets, net?: Amgen (AMGN) reported finite-lived intangible assets, net of $22.43B in Q3 2025.
How has Amgen's finite-lived intangible assets, net changed year-over-year?: Amgen's finite-lived intangible assets, net decreased by 19.4% year-over-year, from $27.83B to $22.43B.
What is the long-term trend for Amgen's finite-lived intangible assets, net?: Over 4 years (2020 to 2024), Amgen's finite-lived intangible assets, net has grown at a 12.6% compound annual growth rate (CAGR), from $16.56B to $26.64B.
What does finite-lived intangible assets, net mean?: The current book value of intangible assets with a limited lifespan after accounting for wear and tear.